...
首页> 外文期刊>The Journal of Pharmacology and Experimental Therapeutics: Official Publication of the American Society for Pharmacology and Experimental Therapeutics >The modulation of vascular ATP-sensitive K+ channel function via the phosphatidylinositol 3-kinase-Akt pathway activated by phenylephrine.
【24h】

The modulation of vascular ATP-sensitive K+ channel function via the phosphatidylinositol 3-kinase-Akt pathway activated by phenylephrine.

机译:通过去氧肾上腺素激活的磷脂酰肌醇3-激酶-Akt途径调节血管ATP敏感性K +通道功能。

获取原文
获取原文并翻译 | 示例
           

摘要

The present study examined the modulator role of the phosphatidylinositol 3-kinase (PI3K)-Akt pathway activated by the alpha-1 adrenoceptor agonist phenylephrine in ATP-sensitive K(+) channel function in intact vascular smooth muscle. We evaluated the ATP-sensitive K(+) channel function and the activity of the PI3K-Akt pathway in the rat thoracic aorta without endothelium. The PI3K inhibitor 2-(4-morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY294002) (10(-5) M) augmented relaxation in response to the ATP-sensitive K(+) channel opener levcromakalim (10(-8) to 3 x 10(-6) M) in aortic rings contracted with phenylephrine (3 x 10(-7) M) but not with 9,11-dideoxy-11alpha,9alpha-epoxy-methanoprostaglandin F(2alpha) (U46619; 3 x 10(-8) M), although those agents induced similar contraction. ATP-sensitive K(+) channel currents induced by levcromakalim (10(-6) M) in the presence of phenylephrine (3 x 10(-7) M) were enhanced by the nonselective alpha-adrenoceptor antagonist phentolamine (10(-7) M) and LY294002 (10(-5) M). Levels of the regulatory subunits of PI3K p85-alpha and p55-gamma increased in the membrane fraction from aortas without endothelium treated with phenylephrine (3 x 10(-7) M) but not with U46619 (3 x 10(-8) M). Phenylephrine simultaneously augmented Akt phosphorylation at Ser473 and Thr308. Therefore, activation of the PI3K-Akt pathway seems to play a role in the impairment of ATP-sensitive K(+) channel function in vascular smooth muscle exposed to alpha-1 adrenergic stimuli.
机译:本研究检查了α-1肾上腺素受体激动剂去氧肾上腺素激活的磷脂酰肌醇3-激酶(PI3K)-Akt通路在完整血管平滑肌中ATP敏感K(+)通道功能中的调节作用。我们评估了ATP敏感性K(+)通道功能和PI3K-Akt通路在无内皮大鼠胸主动脉中的活性。 PI3K抑制剂2-(4-吗啉基)-8-苯基-1(4H)-苯并吡喃-4-酮盐酸盐(LY294002)(10(-5)M)增强了对ATP敏感的K(+)的响应通道开放剂levcromakalim(10(-8)至3 x 10(-6)M)在主动脉环中与去氧肾上腺素(3 x 10(-7)M)收缩但与9,11-dideoxy-11alpha,9alpha-epoxy-甲氧前列腺素F(2alpha)(U46619; 3 x 10(-8)M),尽管这些药物诱导相似的收缩。非选择性α-肾上腺素受体拮抗剂苯妥拉明(10(-7)在左肾上腺素(3 x 10(-7)M)的存在下,由左克莫卡林(10(-6)M)诱导的ATP敏感K(+)通道电流得到增强。 )M)和LY294002(10(-5)M)。在未用去氧肾上腺素(3 x 10(-7)M)内皮但未用U46619(3 x 10(-8)M)处理的主动脉中,PI3K p85-alpha和p55-γ调节亚基的水平在主动脉膜部分增加。苯肾上腺素同时增强了Ser473和Thr308的Akt磷酸化。因此,PI3K-Akt途径的激活似乎在暴露于α-1肾上腺素刺激的血管平滑肌中ATP敏感性K(+)通道功能的损害中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号